• Harnessing Precision γ-Secretase Inhibition: Strategic Gu...

  2025-10-22

  This thought-leadership article provides translational researchers with an integrated roadmap for leveraging LY-411575—a potent γ-secretase inhibitor with ultra-low IC50—in Alzheimer’s and oncology models. Blending mechanistic insight, recent immuno-oncology findings, and practical workflow considerations, we illustrate how LY-411575’s dual action on amyloid beta production and Notch signaling enables advanced experimental strategies. Distinct from standard product descriptions, this piece explores next-generation applications, including immune microenvironment modulation and combination therapies, contextualized with pivotal evidence from the latest peer-reviewed studies.

• LY2603618: Selective Chk1 Inhibitor for Precision Cell Cy...

  2025-10-21

  LY2603618 is a highly selective checkpoint kinase 1 inhibitor that revolutionizes DNA damage response research by enabling precise G2/M cell cycle arrest and synergistic chemotherapy sensitization. Its ATP-competitive mechanism and robust activity in non-small cell lung cancer models set it apart for both mechanistic studies and translational oncology workflows.

242 records 17/17 page Previous First page 上5页 1617